Get startedLog in
    Picture of H Lundbeck A/S logo

    HLUN A — H Lundbeck A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareBalancedLarge CapSuper Stock
    All News

    Otsuka And Lundbeck Submit SNDA For FDA Review Of Brexpiprazole And Sertraline Combination As Potential Treatment For Ptsd

    Picture of H Lundbeck A/S logoH Lundbeck A/S
    09/04/2024 07:02
    April 9 (Reuters) - Otsuka Holdings Co Ltd  4578.T :
    * OTSUKA HOLDINGS CO LTD: OTSUKA AND LUNDBECK SUBMIT SNDA
FOR FDA
REVIEW OF BREXPIPRAZOLE AND SERTRALINE COMBINATION AS POTENTIAL
TREATMENT FOR PTSD

Source text for Eikon:  ID:nTSpi8a94e 
Further company coverage:  4578.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))

    Recent news on H Lundbeck A/S

    See all news